Atlas of diabetes

Por Skyler, Jay.
Publicado em 2012

Update on Worldwide Efforts to Prevent Type 1 Diabetes

Por Skyler, Jay S.
Publicado em 2008

The Compelling Case for Anti-CD3 in Type 1 Diabetes

Por Skyler, Jay S.
Publicado em 2013

Immune Intervention for Type 1 Diabetes, 2013–2014

Por Skyler, Jay S.
Publicado no Diabetes Technol Ther (2015)

Immune therapy for treating type 1 diabetes: challenging existing paradigms

Por Skyler, Jay S.
Publicado no J Clin Invest (2014)

Stopping Type 1 Diabetes: Attempts to Prevent or Cure Type 1 Diabetes in Man

Por Skyler, Jay S., Ricordi, Camillo
Publicado em 2011

Immunotherapy Trials for Type 1 Diabetes: The Contribution of George Eisenbarth

Por Skyler, Jay S., Pugliese, Alberto
Publicado em 2013

George S. Eisenbarth: Insulin and Type 1 Diabetes

Por Pugliese, Alberto, Skyler, Jay S.
Publicado em 2013

Type 1 Diabetes at a Crossroads!

Por Cefalu, William T., Tamborlane, William V., Skyler, Jay S.
Publicado no Diabetes Care (2015)

Meta-analysis of safety for low event-rate binomial trials

Por Shuster, Jonathan J, Guo, Jennifer D., Skyler, Jay S.
Publicado em 2012

The Development, Validation, and Utility of the Diabetes Prevention Trial-Type 1 Risk Score (DPTRS)

Por Sosenko, Jay M., Skyler, Jay S., Palmer, Jerry P.
Publicado no Curr Diab Rep (2015)

Allogeneic Mesenchymal Precursor Cells in Type 2 Diabetes: A Randomized, Placebo-Controlled, Dose-Escalation Safety and Tolerability Pilot Study

Por Skyler, Jay S., Fonseca, Vivian A., Segal, Karen R., Rosenstock, Julio
Publicado no Diabetes Care (2015)

Progression to Diabetes in Relatives of Type 1 Diabetic Patients: Mechanisms and Mode of Onset

Por Ferrannini, Ele, Mari, Andrea, Nofrate, Valentina, Sosenko, Jay M., Skyler, Jay S.
Publicado em 2010

The Metabolic Progression to Type 1 Diabetes as Indicated by Serial Oral Glucose Tolerance Testing in the Diabetes Prevention Trial–Type 1

Por Sosenko, Jay M., Skyler, Jay S., Herold, Kevan C., Palmer, Jerry P.
Publicado em 2012

Effect of Oral Insulin on Prevention of Diabetes in Relatives of Patients With Type 1 Diabetes: A Randomized Clinical Trial

Por Krischer, Jeffrey P., Schatz, Desmond A., Bundy, Brian, Skyler, Jay S., Greenbaum, Carla J.
Publicado no JAMA (2017)

Prognostic Accuracy of Immunologic and Metabolic Markers for Type 1 Diabetes in a High-Risk Population: Receiver operating characteristic analysis

Por Xu, Ping, Beam, Craig A., Cuthbertson, David, Sosenko, Jay M., Skyler, Jay S., Krischer, Jeffrey P.
Publicado em 2012

Type 1 Diabetes TrialNet – An International Collaborative Clinical Trials Network

Por Skyler, Jay S., Greenbaum, Carla J., Lachin, John M., Leschek, Ellen, Rafkin-Mervis, Lisa, Savage, Peter, Spain, Lisa
Publicado em 2008

Glucose and C-Peptide Changes in the Perionset Period of Type 1 Diabetes in the Diabetes Prevention Trial–Type 1

Por Sosenko, Jay M., Palmer, Jerry P., Rafkin-Mervis, Lisa, Krischer, Jeffrey P., Cuthbertson, David, Matheson, Della, Skyler, Jay S.
Publicado em 2008

Effect of Ranolazine Monotherapy on Glycemic Control in Subjects With Type 2 Diabetes

Por Eckel, Robert H., Henry, Robert R., Yue, Patrick, Dhalla, Arvinder, Wong, Pamela, Jochelson, Philip, Belardinelli, Luiz, Skyler, Jay S.
Publicado no Diabetes Care (2015)

Sample Size Requirements for Studies of Treatment Effects on Beta-Cell Function in Newly Diagnosed Type 1 Diabetes

Por Lachin, John M., McGee, Paula L., Greenbaum, Carla J., Palmer, Jerry, Pescovitz, Mark D., Gottlieb, Peter, Skyler, Jay
Publicado em 2011